Skip to main content
GENFIT logo

GENFIT — Investor Relations & Filings

Ticker · GNFT ISIN · FR0004163111 LEI · 969500XPWN2DMZQA5X73 PA Professional, scientific and technical activities
Open in API
Filings indexed 681 across all filing types
Latest filing 2017-04-28 Report Publication Anno…
Country FR France
Listing PA GNFT

About GENFIT

https://www.genfit.com

GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.

Recent filings

Filing Released Lang Actions
2017.04.28 CP GENFIT Mise à disposition DDR
Report Publication Announcement Classification · 99% confidence The document is a press release titled "GENFIT : MISE A DISPOSITION DU DOCUMENT DE REFERENCE 2016" (GENFIT: Availability of the 2016 Reference Document). It explicitly states that the 2016 Reference Document (Document de Référence 2016) has been filed with the AMF (Autorité des Marchés Financiers) and is made available to the public. The document itself is short (under 5,000 characters) and serves to announce the publication of a larger report, which includes the annual financial report, governance report, and auditor fees. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report has been published or made available points to a Report Publication Announcement (RPA).
2017-04-28 French
2017.04.05 PR GENFIT EASL ILC 2017
Earnings Release Classification · 99% confidence The document is explicitly titled '# PRESS RELEASE' multiple times and details upcoming presentations of scientific data (biomarkers, compounds, combination therapies) at a specific medical conference (EASL 2017). It announces future events like a satellite symposium and a KOL lunch related to the data presentation. This structure—a formal announcement about upcoming corporate/scientific activities rather than the release of a full periodic financial report (like 10-K or IR) or a transcript of a call—best fits the category for general regulatory announcements or press releases that don't fit elsewhere. Since it is a press release announcing scientific progress and conference participation, and not a formal financial filing, the most appropriate general category is Regulatory Filings (RNS), as it serves as a broad announcement mechanism for non-standard filings. It is not an Earnings Release (ER) as it focuses on R&D data, not period financial results. FY 2017
2017-04-05 English
2017.04.05 CP GENFIT EASL ILC 2017
Earnings Release Classification · 99% confidence The document is explicitly titled 'COMMUNIQUÉ DE PRESSE' (Press Release) multiple times. It announces the company's participation and presentation of data at an upcoming scientific congress (EASL ILC) regarding its NASH research, biomarkers, and drug candidates (elafibranor, nitazoxanide). It details abstracts, poster presentations, and satellite symposiums. This type of announcement, which communicates key business/research updates to the public and media, fits best under the general category for regulatory announcements or press releases that don't fit a more specific financial filing type. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific shareholder communication (DEF 14A, PSI), the most appropriate general category is Regulatory Filings (RNS), which often serves as a catch-all for official company announcements not covered elsewhere, especially when the primary purpose is dissemination of news rather than mandatory financial disclosure. FY 2017
2017-04-05 French
2017.03.28 CP GENFIT KOLs events
Regulatory Filings Classification · 95% confidence The document is explicitly titled "COMMUNIQUÉ DE PRESSE" (Press Release) multiple times. It announces a series of Key Opinion Leader (KOL) meetings regarding NASH management, scheduled for specific dates in March and April 2017 in various US and European cities. This type of announcement, detailing future corporate events, presentations, or informational roadshows aimed at investors and analysts, fits best under the category of general corporate communication or investor relations material. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific regulatory filing, and it is focused on communicating company activities and pipeline updates to the financial community via a press release format, it aligns most closely with a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were the presentation itself. However, as an announcement *about* upcoming informational meetings, RNS serves as the best general fit for non-standard corporate news releases that don't fit the other specific categories like DIV, DIRS, or ER. Given the context of communicating upcoming investor/analyst events, RNS is the most appropriate fallback for a press release of this nature.
2017-03-28 French
2017.03.28 PR GENFIT KOLs events
Regulatory Filings Classification · 95% confidence The document is explicitly titled '# PRESS RELEASE' at the beginning and end. It announces future events ('GENFIT to host a series of KOL Meetings in NASH') intended for institutional investors and research analysts, detailing dates, locations, and speakers. This type of communication, which announces corporate activities, events, or preliminary results outside of a formal regulatory filing structure (like 10-K or IR), is best classified as a general announcement. Since it is not a formal Earnings Release (ER) which focuses on financial figures, nor a specific report like an Audit Report (AR) or Interim Report (IR), the most appropriate general category for corporate news announcements that don't fit elsewhere is Regulatory Filings (RNS), which serves as a broad category for miscellaneous regulatory/corporate news releases.
2017-03-28 English
2017.02.14 CP GENFIT Evenement inaugural NASH EP
Regulatory Filings Classification · 95% confidence The document is explicitly titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces an upcoming event: the inaugural press conference for the launch of 'The NASH Education ProgramTM' foundation. It details the date, location, speakers, and the purpose of the event. This structure—an announcement of a future event or initiative via a press release—does not fit the definitions for a full Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or Investor Presentation (IP). Since it is a formal announcement released to the public/media regarding a specific corporate action (launching an educational foundation/program), and it is not a standard regulatory filing like DIRS or DIV, the most appropriate general category for a corporate announcement that doesn't fit a highly specific financial report type is 'Regulatory Filings' (RNS), which serves as a broad category for official company communications not covered elsewhere, or potentially a general announcement if the context implies a broad communication strategy. Given the nature of announcing a press conference for a new foundation, it is a general corporate communication. RNS is the best fit among the provided options for a press release announcing a non-financial event/initiative.
2017-02-14 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.